These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20534391)

  • 21. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.
    Vincent S; Djulbegovic B
    Cancer Treat Rev; 2005 Jun; 31(4):319-22. PubMed ID: 16006047
    [No Abstract]   [Full Text] [Related]  

  • 22. New surgical procedures diagnose, cure, and palliate cancer.
    Mast ME
    ONS News; 2001 Oct; 16(10):4-6. PubMed ID: 12607461
    [No Abstract]   [Full Text] [Related]  

  • 23. Invited commentary-WHO Classification of Tumours: How should tumors be classified? Expert consensus, systematic reviews or both?
    Uttley L; Indave BI; Hyde C; White V; Lokuhetty D; Cree I
    Int J Cancer; 2020 Jun; 146(12):3516-3521. PubMed ID: 32170735
    [No Abstract]   [Full Text] [Related]  

  • 24. What constitutes the "optimal" treatment environment of women with gynecologic cancer?
    Orr JW
    Gynecol Oncol; 2003 Apr; 89(1):1-3. PubMed ID: 12694646
    [No Abstract]   [Full Text] [Related]  

  • 25. Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls.
    Keefe DM; Peterson DE; Schubert MM
    Support Care Cancer; 2006 Jun; 14(6):492-8. PubMed ID: 16601949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?
    Oseso LN; Chiao EY; Bender Ignacio RA
    J Natl Compr Canc Netw; 2018 Aug; 16(8):927-932. PubMed ID: 30099368
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidance on the creation of evidence-linked guidelines for COIN.
    Rosalki JR; Karp SJ
    Clin Oncol (R Coll Radiol); 1999; 11(1):28-32. PubMed ID: 10194583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuro-oncology: setting new standards of management.
    Graus F; Tortosa A
    Lancet Neurol; 2006 Jan; 5(1):8-9. PubMed ID: 16361010
    [No Abstract]   [Full Text] [Related]  

  • 29. ESMO clinical recommendations: a practical guide for medical oncologists.
    Pavlidis N; Hansen H; Stahel R
    Ann Oncol; 2007 Nov; 18(11):1759-63. PubMed ID: 17921244
    [No Abstract]   [Full Text] [Related]  

  • 30. A health services research agenda to fully integrate cancer rehabilitation into oncology care.
    Pergolotti M; Alfano CM; Cernich AN; Yabroff KR; Manning PR; de Moor JS; Hahn EE; Cheville AL; Mohile SG
    Cancer; 2019 Nov; 125(22):3908-3916. PubMed ID: 31390063
    [No Abstract]   [Full Text] [Related]  

  • 31. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk analysis in surgical oncology-part II: risk and the practising surgeon.
    Rew DA
    Eur J Surg Oncol; 2000 Nov; 26(7):705-10. PubMed ID: 11187028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striving to improve outcomes in oncology: unmet expectations in a complex disease.
    Bates SE
    Clin Cancer Res; 2010 Dec; 16(24):5950. PubMed ID: 21169246
    [No Abstract]   [Full Text] [Related]  

  • 34. Currently available quality improvement initiatives in surgical oncology.
    Merkow RP; Bilimoria KY
    Surg Oncol Clin N Am; 2012 Jul; 21(3):367-75, vii. PubMed ID: 22583986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life as an outcome variable in oncology and surgery.
    Gough IR
    Aust N Z J Surg; 1994 Apr; 64(4):227-35. PubMed ID: 8147772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Patient-Reported Outcomes in Postsurgical Monitoring in Oncology.
    Smith AB; Basch E
    J Oncol Pract; 2017 Aug; 13(8):535-538. PubMed ID: 28682667
    [No Abstract]   [Full Text] [Related]  

  • 37. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 38. Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology.
    Serpas VJ; Raghav KP; Halperin DM; Yao J; Overman MJ
    BMC Med Res Methodol; 2018 Dec; 18(1):169. PubMed ID: 30541475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual Oncological Networks--IT Support for an Evidence-based, Oncological Health Care Management.
    Heiden K; Sinha M; Böckmann B
    Stud Health Technol Inform; 2015; 216():953. PubMed ID: 26262255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.